Orchard Therapeutics Plc (ORTX) Inventory Turnover Ratio, from third quarter 2023 to third quarter 2022, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Orchard Therapeutics Plc  (NASDAQ: ORTX)
 

Orchard Therapeutics Plc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Orchard Therapeutics Plc's inventory turnover ratio, the ratio that measures Orchard Therapeutics Plc's ability to manage its supply chain, sequentially decreased to 1.2 in the third quarter 2023, which does not come as a surprise, as the Orchard Therapeutics Plc continue to experience headwinds, which also impact its supply chain. Orchard Therapeutics Plc's average inventory processing period in the Sep 30 2023 quarter, has increased to 304 days, from 250 days, in the Jun 30 2023 quarter.

Within Healthcare sector 327 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1926 in the second quarter 2023, to 1990.

ORTX Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Orchard Therapeutics Plc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ORTX Inventory Turnover Ratio (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter
Y / Y Inventory Growth 184.4 % 261.49 % 208.78 % 68.65 % 36.33 %
Y / Y Cost of Sales Growth 6.08 % 95.1 % -76.64 % - 627.88 %
Inventory Turnover Ratio (TTM) 1.2 1.46 1.69 2.87 2.15
ORTX's Total Ranking # 1990 # 1926 # 1897 # 1552 # 1778
Average inventory processing period 305 251 216 127 170
Seq. Inventory Growth -4.31 % 24.88 % 63.38 % 45.67 % 21.63 %
Seq. Cost of Sales Growth -20.28 % 496.46 % -84.92 % 47.9 % 46.61 %




Inventory Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 21
Healthcare Sector # 328
Overall Market # 1990

Inventory Turnover Ratio Statistics
High Average Low
2.87 1.36 0.14
(Dec 31 2022)   (Dec 31 2021)



ORTX Company Profile >> Back to ORTX Efficiency Comparisons >> Compare ORTX Inventory Turnover Ratio to its Competitors

Financial Statements
Orchard Therapeutics Plc's Inventories $ 7 Millions Visit ORTX's Balance sheet
Orchard Therapeutics Plc's Cost of Revenues TTM $ 7 Millions Visit ORTX's Income Statement
What are ORTX's Sales? Visit ORTX's Sales by Segment

Other Inventory Turnover Ratios
Orchard Therapeutics Plc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ORTX's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ORTX's Competitors
Inventory Turnover Ratio for ORTX's Suppliers
Inventory Turnover Ratio for ORTX's Customers

You may also want to know
ORTX's Sales Growth Rates ORTX's Pe Price to earnings ratio ORTX's Receivables Turnover Ratio ORTX's Stock Quote
ORTX's Net Income Growth Rates ORTX's Ps Price to Sales ratio ORTX's Sales per Employee ORTX's Asset Turnover Ratio
ORTX's Net Margin ORTX's Pb Price to Book ratio ORTX's Financial Strength Ratios ORTX's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2023 Inventories at quarter ending Sep 30 2023
Pfizer Inc  2.77 $ 27,041.000  Millions$ 9,759  Millions
Iridex Corp  2.74 $ 29.531  Millions$ 11  Millions
Msa Safety Inc  2.74 $ 924.000  Millions$ 337  Millions
Waters Corporation  2.73 $ 1,225.053  Millions$ 448  Millions
Abbott Laboratories  2.73 $ 18,012.000  Millions$ 6,592  Millions
Merck and Co Inc   2.70 $ 16,095.000  Millions$ 5,959  Millions
Hologic Inc  2.69 $ 1,788.500  Millions$ 666  Millions
Electromedical Technologies Inc   2.68 $ 0.313  Millions$ 0  Millions
Skinhealth Systems Inc   2.67 $ 280.806  Millions$ 105  Millions
Zynex inc   2.67 $ 37.482  Millions$ 14  Millions
Axsome Therapeutics Inc   2.66 $ 20.978  Millions$ 8  Millions
Quanterix Corporation  2.66 $ 48.002  Millions$ 18  Millions
Logicmark Inc  2.62 $ 3.271  Millions$ 1  Millions
International Stem Cell Corporation  2.61 $ 3.454  Millions$ 1  Millions
Amphastar Pharmaceuticals Inc   2.61 $ 275.164  Millions$ 105  Millions
Perrigo Company Plc  2.60 $ 3,018.000  Millions$ 1,163  Millions
Lifevantage Corp  2.58 $ 43.058  Millions$ 17  Millions
Jin Medical International Ltd  2.58 $ 13.037  Millions$ 5  Millions
Viatris Inc   2.58 $ 9,349.400  Millions$ 3,624  Millions
Akebia Therapeutics Inc   2.54 $ 51.682  Millions$ 20  Millions
Staar Surgical Co  2.52 $ 68.475  Millions$ 27  Millions
Johnson and Johnson  2.51 $ 30,978.000  Millions$ 12,345  Millions
Silk Road Medical Inc   2.50 $ 48.505  Millions$ 19  Millions
Cue Health Inc   2.46 $ 182.132  Millions$ 74  Millions
Inotiv Inc   2.46 $ 153.677  Millions$ 62  Millions
Embecta Corp   2.46 $ 370.000  Millions$ 151  Millions
Phibro Animal Health Corporation  2.45 $ 678.125  Millions$ 277  Millions
Tvardi Therapeutics Inc   2.45 $ 7.696  Millions$ 3  Millions
Dariohealth Corp   2.44 $ 16.001  Millions$ 7  Millions
Zai Lab Limited  2.43 $ 91.503  Millions$ 38  Millions

Date modified: 2026-06-23T20:00:26+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.